{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T16:38:34Z","timestamp":1791131914467,"version":"4.1.0"},"reference-count":89,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2010,2,19]],"date-time":"2010-02-19T00:00:00Z","timestamp":1266537600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0009313","type":"journal-article","created":{"date-parts":[[2010,2,18]],"date-time":"2010-02-18T22:50:05Z","timestamp":1266533405000},"page":"e9313","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":345,"title":["Selective Molecular Alterations in the Autophagy Pathway in Patients with Lewy Body Disease and in Models of \u03b1-Synucleinopathy"],"prefix":"10.1371","volume":"5","author":[{"given":"Leslie","family":"Crews","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Desplats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Patrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Paulino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Rockenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Adame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Galasko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliezer","family":"Masliah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2010,2,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"14524","DOI":"10.1073\/pnas.172514599","article-title":"Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP.","volume":"99","author":"W Dauer","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models.","volume":"39","author":"W Dauer","year":"2003","journal-title":"Neuron"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/0929866043407174","article-title":"Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration.","volume":"11","author":"DM Walsh","year":"2004","journal-title":"Protein Pept Lett"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0166-2236(00)01749-5","article-title":"Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?","volume":"24","author":"WL Klein","year":"2001","journal-title":"Trends Neurosci"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1385\/NMM:4:1-2:21","article-title":"Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.","volume":"4","author":"M Hashimoto","year":"2003","journal-title":"Neuromolecular Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1046\/j.1471-4159.2001.00149.x","article-title":"Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult.","volume":"76","author":"M Lee","year":"2001","journal-title":"J Neurochem"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.290.5493.985","article-title":"Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.","volume":"290","author":"BI Giasson","year":"2000","journal-title":"Science"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0022-2836(02)00735-0","article-title":"Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils.","volume":"322","author":"HA Lashuel","year":"2002","journal-title":"J Mol Biol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/418291a","article-title":"Neurodegenerative disease: amyloid pores from pathogenic mutations.","volume":"418","author":"HA Lashuel","year":"2002","journal-title":"Nature"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1212\/01.wnl.0000256715.13907.d3","article-title":"DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers.","volume":"68","author":"CF Lippa","year":"2007","journal-title":"Neurology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0733-8619(05)70230-9","article-title":"Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia.","volume":"18","author":"IG McKeith","year":"2000","journal-title":"Neurol Clin"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","article-title":"Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop.","volume":"47","author":"IG McKeith","year":"1996","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/01.wco.0000247607.34697.a2","article-title":"Cortical Lewy body disease and Parkinson's disease dementia.","volume":"19","author":"DJ Burn","year":"2006","journal-title":"Curr Opin Neurol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/0891988704267470","article-title":"Are Parkinson's disease with dementia and dementia with Lewy bodies the same entity?","volume":"17","author":"D Aarsland","year":"2004","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00401-006-0088-2","article-title":"Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies?","volume":"112","author":"KA Jellinger","year":"2006","journal-title":"Acta Neuropathol (Berl)"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archneur.55.7.969","article-title":"Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study.","volume":"55","author":"I Litvan","year":"1998","journal-title":"Arch Neurol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/mds.20726","article-title":"Cognitive profiles of individual patients with Parkinson's disease and dementia: comparison with dementia with lewy bodies and Alzheimer's disease.","volume":"21","author":"CC Janvin","year":"2006","journal-title":"Mov Disord"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.","volume":"65","author":"IG McKeith","year":"2005","journal-title":"Neurology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"12245","DOI":"10.1073\/pnas.211412398","article-title":"beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.","volume":"98","author":"E Masliah","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s11064-006-9140-9","article-title":"Interaction between Abeta peptide and alpha synuclein: molecular mechanisms in overlapping pathology of Alzheimer's and Parkinson's in dementia with Lewy body disease.","volume":"31","author":"PK Mandal","year":"2006","journal-title":"Neurochem Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e3135","DOI":"10.1371\/journal.pone.0003135","article-title":"Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases.","volume":"3","author":"IF Tsigelny","year":"2008","journal-title":"PLoS ONE"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s12640-009-9073-6","article-title":"Role of synucleins in Alzheimer's disease.","volume":"16","author":"L Crews","year":"2009","journal-title":"Neurotox Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","article-title":"Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy.","volume":"305","author":"AM Cuervo","year":"2004","journal-title":"Science"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/jnen\/62.5.451","article-title":"Lysosomal activation is a compensatory response against protein accumulation and associated synaptopathogenesis\u2013an approach for slowing Alzheimer disease?","volume":"62","author":"J Bendiske","year":"2003","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1126\/science.290.5497.1717","article-title":"Autophagy as a regulated pathway of cellular degradation.","volume":"290","author":"DJ Klionsky","year":"2000","journal-title":"Science"},{"key":"ref26","first-page":"159","article-title":"Eating oneself and uninvited guests: autophagy-related pathways in cellular defense.","volume":"120","author":"B Levine","year":"2005","journal-title":"Cell"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.tcb.2003.12.002","article-title":"Autophagy: in sickness and in health.","volume":"14","author":"AM Cuervo","year":"2004","journal-title":"Trends Cell Biol"},{"key":"ref28","first-page":"897","article-title":"Autophagy in neurons: a review.","volume":"17","author":"KE Larsen","year":"2002","journal-title":"Histol Histopathol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/01.jnen.0000229233.75253.be","article-title":"Autophagic stress in neuronal injury and disease.","volume":"65","author":"CT Chu","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ceb.2004.09.011","article-title":"Death by design: apoptosis, necrosis and autophagy.","volume":"16","author":"AL Edinger","year":"2004","journal-title":"Curr Opin Cell Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1471-4159.2002.01192.x","article-title":"The neuropathogenic contributions of lysosomal dysfunction.","volume":"83","author":"BA Bahr","year":"2002","journal-title":"J Neurochem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jnen\/64.2.113","article-title":"Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study.","volume":"64","author":"RA Nixon","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3233\/JAD-2006-9S331","article-title":"Lysosomal system pathways: genes to neurodegeneration in Alzheimer's disease.","volume":"9","author":"RA Nixon","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"ref34","first-page":"2190","article-title":"The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice.","volume":"118","author":"F Pickford","year":"2008","journal-title":"J Clin Invest"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/jnr.20446","article-title":"Lysosomal pathology associated with alpha-synuclein accumulation in transgenic models using an eGFP fusion protein.","volume":"80","author":"E Rockenstein","year":"2005","journal-title":"J Neurosci Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.biocel.2004.05.008","article-title":"Involvement of macroautophagy in the dissolution of neuronal inclusions.","volume":"36","author":"HJ Rideout","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.brainres.2005.01.099","article-title":"Alpha-synuclein-positive structures induced in leupeptin-infused rats.","volume":"1040","author":"T Nakajima","year":"2005","journal-title":"Brain Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0006-8993(02)03514-X","article-title":"Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease.","volume":"956","author":"GE Meredith","year":"2002","journal-title":"Brain Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"9549","DOI":"10.1523\/JNEUROSCI.21-24-09549.2001","article-title":"Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death.","volume":"21","author":"L Stefanis","year":"2001","journal-title":"J Neurosci"},{"key":"ref40","first-page":"777","article-title":"Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy.","volume":"118","author":"M Martinez-Vicente","year":"2008","journal-title":"J Clin Invest"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e5515","DOI":"10.1371\/journal.pone.0005515","article-title":"Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy.","volume":"4","author":"M Xilouri","year":"2009","journal-title":"PLoS ONE"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"13578","DOI":"10.1523\/JNEUROSCI.4390-09.2009","article-title":"Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases.","volume":"29","author":"B Spencer","year":"2009","journal-title":"J Neurosci"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ajmg.a.10028","article-title":"Gaucher disease associated with parkinsonism: four further case reports.","volume":"116","author":"J Varkonyi","year":"2003","journal-title":"Am J Med Genet A"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/mgme.2001.3201","article-title":"Gaucher disease and parkinsonism: a phenotypic and genotypic characterization.","volume":"73","author":"N Tayebi","year":"2001","journal-title":"Mol Genet Metab"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/jnen\/63.4.323","article-title":"Aberrant phosphorylation of alpha-synuclein in human Niemann-Pick type C1 disease.","volume":"63","author":"Y Saito","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/01.jnen.0000225908.90052.07","article-title":"Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy.","volume":"65","author":"H Uchikado","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref47","first-page":"111","article-title":"The Lewy body variant of Alzheimer disease.","volume":"51","author":"L Hansen","year":"1997","journal-title":"JNeural Transm"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"II3","DOI":"10.1007\/PL00007758","article-title":"Pathoanatomy of Parkinson's disease.","volume":"247","author":"H Braak","year":"2000","journal-title":"J Neurol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00019052-200108000-00001","article-title":"Alpha-synuclein and the Lewy body disorders.","volume":"14","author":"DW Dickson","year":"2001","journal-title":"Curr Opin Neurol"},{"key":"ref50","article-title":"Neocortical synaptophysin in Lewy body disease: relationship to Alzheimer's disease and dementia.","author":"L Hansen","year":"1998","journal-title":"JNeurolNeurosurgPsych"},{"key":"ref51","first-page":"269","article-title":"Entorhinal neurofibrillary tangles in Alzheimer disease with Lewy bodies.","volume":"129","author":"L Hansen","year":"1991","journal-title":"NeurosciLett"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes.","volume":"82","author":"H Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3233\/JAD-2006-9S347","article-title":"Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop.","volume":"9","author":"IG McKeith","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"ref54","first-page":"77","article-title":"Neuropathology of Alzheimer's disease: a critical update.","volume":"Transm","author":"KA Jellinger","year":"1998","journal-title":"J Neural"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","article-title":"Dopaminergic loss and inclusion body formation in alpha-synuclein mice: Implications for neurodegenerative disorders.","volume":"287","author":"E Masliah","year":"2000","journal-title":"Science"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/jnr.10231","article-title":"Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters.","volume":"68","author":"E Rockenstein","year":"2002","journal-title":"J Neurosci Res"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.neuron.2005.05.010","article-title":"Effects of alpha-Synuclein Immunization in a Mouse Model of Parkinson's Disease.","volume":"46","author":"E Masliah","year":"2005","journal-title":"Neuron"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1523\/JNEUROSCI.20-11-04050.2000","article-title":"High-level neuronal expression of abeta 1\u201342 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.","volume":"20","author":"L Mucke","year":"2000","journal-title":"J Neurosci"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/exnr.2001.7684","article-title":"Role of apolipoprotein E receptors in regulating the differential in vivo neurotrophic effects of apolipoprotein E.","volume":"170","author":"I Veinbergs","year":"2001","journal-title":"Exp Neurol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.272.5259.263","article-title":"In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.","volume":"272","author":"L Naldini","year":"1996","journal-title":"Science"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nprot.2006.36","article-title":"Design and cloning of lentiviral vectors expressing small interfering RNAs.","volume":"1","author":"G Tiscornia","year":"2006","journal-title":"Nat Protoc"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1523\/JNEUROSCI.23-06-01992.2003","article-title":"Neprilysin gene transfer reduces human amyloid pathology in transgenic mice.","volume":"23","author":"RA Marr","year":"2003","journal-title":"J Neurosci"},{"key":"ref63","first-page":"141","article-title":"Reduced neuritic outgrowth and cell adhesion in neuronal cells transfected with human \u03b1-synuclein.","volume":"17","author":"T Takenouchi","year":"2001","journal-title":"MolCell Neurosci"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1046\/j.1471-4159.2003.01791.x","article-title":"Alpha-synuclein up-regulates expression of caveolin-1 and down-regulates extracellular signal-regulated kinase activity in B103 neuroblastoma cells: role in the pathogenesis of Parkinson's disease.","volume":"85","author":"M Hashimoto","year":"2003","journal-title":"J Neurochem"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1212\/01.WNL.0000073987.79060.4B","article-title":"Abeta1-42 promotes cholinergic sprouting in patients with AD and Lewy body variant of AD.","volume":"61","author":"E Masliah","year":"2003","journal-title":"Neurology"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1084\/jem.181.4.1551","article-title":"Protection against HIV-1 gp120-induced brain damage by neuronal overexpression of human amyloid precursor protein (hAPP).","volume":"181","author":"L Mucke","year":"1995","journal-title":"JExpMed"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/367188a0","article-title":"Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice.","volume":"367","author":"S Toggas","year":"1994","journal-title":"Nature"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"32985","DOI":"10.1074\/jbc.M202803200","article-title":"Fibroblast growth factor 1 regulates signaling via the GSK3{beta} pathway: implications for neuroprotection.","volume":"277","author":"M Hashimoto","year":"2002","journal-title":"J Biol Chem"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/00004872-200103001-00010","article-title":"Subcellular localization of angiotensin II in kidney and adrenal.","volume":"19","author":"JP van Kats","year":"2001","journal-title":"J Hypertens"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0006-8993(01)02772-X","article-title":"Altered expression of the synuclein family mRNA in Lewy body and Alzheimer's disease.","volume":"914","author":"E Rockenstein","year":"2001","journal-title":"Brain Res"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1432-1033.1997.0240a.x","article-title":"The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes.","volume":"243","author":"EF Blommaart","year":"1997","journal-title":"Eur J Biochem"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1042\/BST0370232","article-title":"Nutrient-dependent regulation of autophagy through the target of rapamycin pathway.","volume":"37","author":"YY Chang","year":"2009","journal-title":"Biochem Soc Trans"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1091\/mbc.E07-10-1048","article-title":"Organization of the pre-autophagosomal structure responsible for autophagosome formation.","volume":"19","author":"T Kawamata","year":"2008","journal-title":"Mol Biol Cell"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"25009","DOI":"10.1074\/jbc.M300227200","article-title":"Alpha-Synuclein is degraded by both autophagy and the proteasome.","volume":"278","author":"JL Webb","year":"2003","journal-title":"J Biol Chem"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0070-2153(06)76003-3","article-title":"Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications.","volume":"76","author":"A Williams","year":"2006","journal-title":"Curr Top Dev Biol"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/hmg\/11.9.1107","article-title":"Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy.","volume":"11","author":"B Ravikumar","year":"2002","journal-title":"Hum Mol Genet"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.nbd.2008.06.003","article-title":"Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement.","volume":"32","author":"T Pan","year":"2008","journal-title":"Neurobiol Dis"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"6926","DOI":"10.1523\/JNEUROSCI.0800-08.2008","article-title":"Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease.","volume":"28","author":"B Boland","year":"2008","journal-title":"J Neurosci"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1039\/b804606a","article-title":"Small molecule enhancers of autophagy for neurodegenerative diseases.","volume":"4","author":"S Sarkar","year":"2008","journal-title":"Mol Biosyst"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng1362","article-title":"Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease.","volume":"36","author":"B Ravikumar","year":"2004","journal-title":"Nat Genet"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/nn.2372","article-title":"Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss.","volume":"12","author":"LS Tain","year":"2009","journal-title":"Nat Neurosci"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2353\/ajpath.2007.060524","article-title":"Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death.","volume":"170","author":"JH Zhu","year":"2007","journal-title":"Am J Pathol"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.nbd.2009.05.023","article-title":"Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions.","volume":"35","author":"Y Chu","year":"2009","journal-title":"Neurobiol Dis"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"9678","DOI":"10.1021\/bi800699v","article-title":"Cathepsin D is the main lysosomal enzyme involved in the degradation of alpha-synuclein and generation of its carboxy-terminally truncated species.","volume":"47","author":"D Sevlever","year":"2008","journal-title":"Biochemistry"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1756-6606-2-5","article-title":"Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo.","volume":"2","author":"V Cullen","year":"2009","journal-title":"Mol Brain"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"8506","DOI":"10.1523\/JNEUROSCI.0924-09.2009","article-title":"Inhibition of autophagy induction delays neuronal cell loss caused by dysfunctional ESCRT-III in frontotemporal dementia.","volume":"29","author":"JA Lee","year":"2009","journal-title":"J Neurosci"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/ng1609","article-title":"Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia.","volume":"37","author":"G Skibinski","year":"2005","journal-title":"Nat Genet"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1212\/01.wnl.0000231510.89311.8b","article-title":"ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B).","volume":"67","author":"N Parkinson","year":"2006","journal-title":"Neurology"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nature04723","article-title":"Loss of autophagy in the central nervous system causes neurodegeneration in mice.","volume":"441","author":"M Komatsu","year":"2006","journal-title":"Nature"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0313935","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"record-id":"64531"},{"DOI":"10.1371\/journal.pone.0313935","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0009313","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T01:09:53Z","timestamp":1588986593000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0009313"}},"subtitle":[],"editor":[{"given":"Tsuneya","family":"Ikezu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,2,19]]},"references-count":89,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2010,2,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0009313","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,19]]}}}